Intravenous Zanamivir: A Viable Option for Critically Ill Patients With Influenza.
Douglas SlainPublished in: The Annals of pharmacotherapy (2020)
The available information suggests that the intravenous formulation of zanamivir offers a viable alternative treatment for critically ill patients with influenza, especially when resistance to other agents is present.